Zydus Wellness Limited has announced that a meeting of its Board of Directors is scheduled for Monday, May 18, 2026. The board will focus on approving the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Additionally, the company will discuss a potential final dividend for the shareholders for the same period.
Board Meeting Agenda
The Board of Directors of Zydus Wellness Limited is set to convene on May 18, 2026. The primary objective of this meeting is to review and approve the financial performance of the company for the quarter and the full financial year ending March 31, 2026. The board will evaluate both standalone and consolidated audited financial results.
Dividend Consideration
In addition to the financial review, the board will consider recommending a final dividend for the financial year ended March 31, 2026. Any recommended dividend will be subject to approval by the members of the company at the upcoming annual general meeting.
Trading Window Update
In adherence to internal corporate governance policies, the trading window for all designated persons and directors will remain closed until May 20, 2026. Trading activities for these individuals are scheduled to resume on Thursday, May 21, 2026.
Source: BSE
